WhatsApp
backNews Article

Stallion India Fluorochemicals Posts 31.8% Revenue Rise in Q2 FY27 Amid Launch of Specialty Gases Unit

H1 FY27 revenue climbs 22.1% to ₹26,404.90 lakh, with Khalapur Helium facility now operational supplying semiconductor and healthcare sectors

Stallion India Fluorochemicals Limited announced a 31.8% year-on-year revenue increase to ₹13,937.33 lakh in Q2 FY27 and sustained double-digit growth in H1 FY27 revenue. The company also commenced operations at its Khalapur high-purity helium facility, targeting semiconductor and healthcare markets.

1 day ago|STALLION+0.55%
Stallion India Fluorochemicals LimitedSTALLIONGeneral / Other

Stallion India Fluorochemicals Limited

General / Other

Stallion India Fluorochemicals Limited reported a 31.8% year-on-year increase in total revenue to ₹13,937.33 lakh for the quarter ending September 30, 2026, with half-year revenue up 22.1% to ₹26,404.90 lakh. The company also announced the operational commencement of its Khalapur high-purity helium gas facility targeting specialty gas markets such as semiconductors and healthcare.

The quarter saw operating profit after tax (PAT), excluding non-cash employee stock option expenses, increase by 4.78% year-on-year to ₹1,196.21 lakh in Q2 FY27 and by 40.2% to ₹3,052.78 lakh for H1 FY27.

The Khalapur Helium Facility is fully operational, supplying high-purity gases used in semiconductor manufacturing, MRI healthcare, aerospace, and defense industries, with sourcing partnerships established with SOC Dubai and Qatar.

The company clarified that the reported non-cash ESOP charge of ₹950.92 lakh under Ind AS 102 has no impact on cash flow and is an accounting provision only, explaining adjusted earnings present the true operating profitability.

Looking ahead, Stallion India Fluorochemicals is progressing projects to expand capacity and backward integration including scaling specialty gases at Khalapur, expanding the Mambattu facility, and advancing next-generation refrigerant molecule R-32 projects.

With over 30 years in the refrigerants and industrial gases markets and five strategic plants across India, the company continues to diversify into high-value specialty segments.

Highlights

  • Q2 FY27 revenue grew 31.8% year-on-year to ₹13,937.33 lakh
  • H1 FY27 revenue reached ₹26,404.90 lakh, up 22.1%
  • Operating PAT for H1 FY27 increased by 40.2% to ₹3,052.78 lakh, before ESOP provisions
  • Khalapur high-purity helium gas facility commenced operations, targeting semiconductor and healthcare sectors
  • Non-cash ESOP charge of ₹950.92 lakh recognized with no impact on cash flow
  • Strategic expansion projects include Mambattu facility growth and R-32 backward integration

Key Data Snapshot

Q2 FY27 Total Revenue₹13,937.33 lakh
Q2 FY27 Operating PAT (Before ESOP Provision)₹1,196.21 lakh
H1 FY27 Total Revenue₹26,404.90 lakh
H1 FY27 Operating PAT (Before ESOP Provision)₹3,052.78 lakh
Non-Cash ESOP Charge in H1 FY27₹950.92 lakh
Khalapur Helium Facility StatusOperational

What happened

  • Stallion India Fluorochemicals posted 31.8% year-on-year revenue growth in Q2 FY27 to ₹13,937.33 lakh and 22.1% growth in H1 FY27 revenue to ₹26,404.90 lakh.
  • Operating profit after tax before ESOP provisions rose 4.78% in Q2 FY27 and 40.2% in H1 FY27.
  • The company started operations at its Khalapur Helium Facility supplying high-purity specialty gases for semiconductor, MRI healthcare, aerospace, and defense industries.
  • The Khalapur facility is supported by sourcing partnerships with SOC Dubai and Qatar.

Key details

  • Non-cash employee stock option compensation amounting to ₹950.92 lakh was recognized in H1 FY27 under Ind AS 102, which is a book entry with no cash outflow.
  • Adjusted operating profitability metrics exclude this ESOP charge for clarity on core earnings.
  • The company aims to expand capacity through the Mambattu plant and backward integrate next-generation refrigerant R-32.
  • Stallion India Fluorochemicals has over 30 years of experience with five manufacturing plants located in Khalapur, Ghiloth, Manesar, and Panvel.

Strategic context

  • The high-purity specialty gases segment like helium targets high-tech industries including semiconductors, healthcare MRI, aerospace, and defense.
  • This diversification aligns with the company’s roadmap involving portfolio depth and regional manufacturing reach expansion.
  • Partnerships with global suppliers support stable supply chains for specialty gases.

More News on General / Other

View all

Latest corporate announcements and market updates in General / Other.

View all news
Stallion India Fluorochemicals Posts 31.8% Revenue Rise | Stockk News